Literature DB >> 7885549

Postoperative hematoma: a 5-year survey and identification of avoidable risk factors.

J D Palmer1, O C Sparrow, F Iannotti.   

Abstract

This study examines the surgical practice at the Wessex Neurological Centre over the 5-year period from 1989 to 1993 to determine the incidence of postoperative hematoma and to identify risk factors for a perioperative bleeding disorder. The study includes only those postoperative hematomas (at any site) that followed and were related to a neurosurgical operation and were surgically evacuated. The study is prospective for the year 1993 and retrospective for the preceding years. Over the 5 years, 6668 operations were performed and 71 postoperative hematomas were surgically evacuated, accounting for an overall rate of 1.1% of operations. The records were available for 69 cases. The most frequent diagnosis leading to postoperative hematoma was meningioma surgery with a rate of 6.2% of cases (13 of 211); followed by craniotomy for trauma, 3.7% (7 of 192); aneurysm surgery, 2.6% (11 of 428); and intrinsic supratentorial tumors, 2.2% (10 of 451). Postoperative hematomas were intraparenchymal in 43% of cases, subdural in 5%, extradural in 33%, mixed in 8%, and confined to the superficial wound in 11%. The overall mortality was 32% (37% for intraparenchymal and 12% for extradural). Risk factors for a perioperative bleeding disorder were present in two-thirds of the patients. Administration of antiplatelet agents (aspirin and nonsteroidal anti-inflammatory drugs) was the most commonly associated risk factor. At least 75% of these identified risk factors could potentially have been avoided or corrected.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7885549     DOI: 10.1227/00006123-199412000-00007

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  51 in total

Review 1.  [Non-opioid analgesics for perioperative pain therapy. Risks and rational basis for use].

Authors:  A Brack; H L Rittner; M Schäfer
Journal:  Anaesthesist       Date:  2004-03       Impact factor: 1.041

2.  Haemostatic changes during surgery for primary brain tumours.

Authors:  K Y Goh; W C Tsoi; C S Feng; N Wickham; W S Poon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

3.  Meningiomas: skull base versus non-skull base.

Authors:  Torstein R Meling; Michele Da Broi; David Scheie; Eirik Helseth
Journal:  Neurosurg Rev       Date:  2018-04-07       Impact factor: 3.042

4.  EXTRADURAL HAEMATOMA FOLLOWING VENTRICULOPERITONEAL SHUNTING.

Authors:  H S Bhatoe; N Kannan
Journal:  Med J Armed Forces India       Date:  2017-06-10

5.  Reoperations after surgery for acute subdural hematoma: reasons, risk factors, and effects.

Authors:  Jan Chrastina; Čeněk Šilar; Tomáš Zeman; Michal Svoboda; Jan Krajsa; Barbora Musilová; Zdeněk Novák
Journal:  Eur J Trauma Emerg Surg       Date:  2019-01-23       Impact factor: 3.693

Review 6.  Post-Craniotomy Pain Management: Beyond Opioids.

Authors:  Lauren K Dunn; Bhiken I Naik; Edward C Nemergut; Marcel E Durieux
Journal:  Curr Neurol Neurosci Rep       Date:  2016-10       Impact factor: 5.081

7.  The Effect of Preoperative Antiplatelet Therapy on Hemorrhagic Complications after Decompressive Craniectomy in Patients with Traumatic Brain Injury.

Authors:  Hokyun Han; Eun Jung Koh; Hyunho Choi; Byong-Cheol Kim; Seung Yeob Yang; Keun-Tae Cho
Journal:  Korean J Neurotrauma       Date:  2016-10-31

8.  Incidence of thromboembolic events after use of gelatin-thrombin-based hemostatic matrix during intracranial tumor surgery.

Authors:  Roberto Gazzeri; Marcelo Galarza; Carlo Conti; Costanzo De Bonis
Journal:  Neurosurg Rev       Date:  2017-04-24       Impact factor: 3.042

Review 9.  How to manage patients with need for antiplatelet therapy in the setting of (un-)planned surgery.

Authors:  Helge Möllmann; Holger M Nef; Christian W Hamm; Albrecht Elsässer
Journal:  Clin Res Cardiol       Date:  2008-10-13       Impact factor: 5.460

10.  Perioperative management of antiplatelet-drugs in cardiac surgery.

Authors:  Raquel Ferrandis; Juan V Llau; Ana Mugarra
Journal:  Curr Cardiol Rev       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.